Human Granzyme B ELISA Kit 检测试剂盒(酶联免疫吸附法)
¥1,600.00 – ¥2,650.00
因产品会迭代升级,具体实验步骤请按纸质版说明书操作
- 分子靶点:GZMB, granzyme B, CTLA1
- 种属:人 (Human)
- 样本类型:血清,血浆,细胞培养上清及其他生物学样本
- 检测样本体积:20 μL
- 灵敏度:3.54 pg/mL
- 检测范围:15.63 pg/mL - 1000 pg/mL
- 回收率:83% - 104%
在售SKU:70-EK158-48, 70-EK158-96, EK158
描述
文章目录[隐藏]
商品名 |
Human Granzyme B ELISA Kit 检测试剂盒(酶联免疫吸附法) |
---|---|
检测方法 |
双抗夹心法 |
精密度 |
板内变异系数:5.5% - 7.0%;板间变异系数:3.8% - 5.4% |
样本类型 |
血清,血浆,细胞培养上清及其他生物学样本 |
检测样本体积 |
20 μL |
灵敏度 |
3.54 pg/mL |
检测范围 |
15.63 pg/mL - 1000 pg/mL |
回收率 |
83% - 104% |
平均回收率 |
0.94 |
板式 |
96孔板,可拆 |
保存 |
试剂盒未拆开,4℃保存。已拆开,标准品-20℃保存,其它4℃保存。 |
运输条件 |
4℃蓝冰运输 |
组分 |
|
检测原理:本试剂盒采用双抗体夹心酶联免疫吸附检测技术。特异性捕获抗体预包被在高亲和力的酶标板上。酶标板孔中加入标准品、待测样本和生物素化的检测抗体,经过孵育,样本中存在的待测物质与捕获抗体和检测抗体结合。洗涤去除未结合的物质后,加入辣根过氧化物酶标记的链霉亲和素(Streptavidin-HRP)。洗涤后,加入显色底物(TMB),避光显色。颜色反应的深浅与样本中待测物质的浓度成正比。加入终止液终止反应,在 450nm 波长(参考波长 570 - 630 nm)测定吸光度值。
GZMB 分子靶点信息概述
- 分子名:GZMB, granzyme B
- 基因家族:Granule associated serine proteases of immune defence
- 别名:CCPI; CGL-1; CSP-B; CGL1; CTSGL1; HLP; SECT
- 曾用名:CTLA1; CSPB
- 全称:fragmentin 2; cytotoxic serine protease B; cathepsin G-like 1; T-cell serine protease 1-3E; granzyme 2; cytotoxic T-lymphocyte-associated serine esterase 1; granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
GZMB 分子靶点综述
颗粒酶 B 是丝氨酸蛋白酶颗粒酶家族的一员,主要存在于细胞毒性 T 淋巴细胞(CTL)和自然杀伤细胞(NK)的颗粒中。颗粒酶 B 利用 Caspase 3、Caspase 8 和 Bid 等底物在颗粒介导的细胞凋亡中发挥重要作用。
作为人类基因组中确定的五种颗粒酶(A、B、H、K 和 M)之一,颗粒酶 B (32kDa)的生物学功能及其在健康和疾病方面的用途得到了最广泛的研究。它被合成为前体(247 个残基),一个信号肽(残基 1-18 个),一个前肽(残基 19-20 个)和一个成熟链(残基 21-247 个)。一旦进入颗粒,Granzyme B 被完全加工成成熟链,当前肽 Gly-Glu 被 Cathepsin c 裂解从 N 端去除时,Granzyme B 成为活性蛋白酶。Granzyme B 的蛋白酶活性受到 Serpin B9/蛋白酶抑制剂 9 的严格控制。
GZMB, granzyme B 分子靶点种属信息
人 Human GZMB 分子靶点信息
- 分子名:GZMB, granzyme B
- 别称:
- C11
- cathepsin G-like 1
- CCPI
- CGL-1
- CGL1
- CSP-B
- CSPB
- CTLA-1
- CTLA1
- CTSGL1
- cytotoxic serine protease B
- cytotoxic T-lymphocyte proteinase 2
- cytotoxic T-lymphocyte-associated serine esterase 1
- fragmentin 2
- fragmentin-2
- granzyme 2
- granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
- granzyme-2
- HLP
- human lymphocyte protein
- lymphocyte protease
- SECT
- T-cell serine protease 1-3E
- 基因序列:NCBI_Gene: 3002
- 蛋白序列:UniProtKB: P10144
人 Human GZMB靶点分子功能(预测)
Enables serine-type endopeptidase activity. Involved in several processes, including granzyme-mediated programmed cell death signaling pathway; natural killer cell mediated cytotoxicity; and pyroptosis. Located in cytolytic granule. Biomarker of COVID-19; bronchiolitis obliterans; and chronic obstructive pulmonary disease.
操作步骤
文章目录[隐藏]
- ELISA操作常见问题
- 血清OR血浆,哪个是ELISA的菜 
- ELISA通关必备丨数据篇丨标准曲线不佳 
- ELISA通关必备丨操作篇丨常见问题及解决方案 
- ELISA通关必备丨操作篇丨溶解与稀释标准品 
- ELISA通关必备丨样本篇丨不常见样本 
- ELISA通关必备丨样本篇丨常见样本丨细胞 
- ELISA通关必备丨如何选择试剂盒 
- ELISA通关必备丨基础知识 
- 真?假?ELISA试剂盒选择要小心 
- ELISA常见类型一 | 双抗夹心法,你要的都在这里! 
- ELISA常见类型二 | 竞争法,五分钟搞定! 
- 叮!联科向您投递了个ELISA实验操作干货包,请查收~ 
- 【视频】ELISA实验操作步骤演示视频教程 
- ELISA 组织样本的处理—大鼠组织 
- 【视频】ELISA实验原理与常见问题分析 
- 查看更多ELISA操作相关问题
ELISA操作常见问题
查看更多ELISA操作相关问题
引用文献
文章目录[隐藏]
- Original research: Switch receptor T3/28 improves long-term persistence and antitumor efficacy of CAR-T cells 
- Single-cell immune profiling reveals functional diversity of T cells in tuberculous pleural effusion 
- CXCL5 impedes CD8+ T cell immunity by upregulating PD-L1 expression in lung cancer via PXN/AKT signaling phosphorylation and neutrophil chemotaxis 
- The TOPK inhibitor HI-TOPK-032 enhances CAR T-cell therapy of hepatocellular carcinoma by upregulating memory T cells 
- Enhanced T cell immune activity mediated by Drp1 promotes the efficacy of PD-1 inhibitors in treating lung cancer 
- Mnox Nanoenzyme Armed CAR-NK Cells Enhance Solid Tumor Immunotherapy by Alleviating the Immunosuppressive Microenvironment 
- Mitochondrial isocitrate dehydrogenase impedes CAR T?cell function by restraining antioxidant metabolism and histone acetylation 
- PLA2G2A+ cancer-associated fibroblasts mediate pancreatic cancer immune escape via impeding antitumor immune response of CD8+ cytotoxic T cells 
Original research: Switch receptor T3/28 improves long-term persistence and antitumor efficacy of CAR-T cells 
Single-cell immune profiling reveals functional diversity of T cells in tuberculous pleural effusion 
CXCL5 impedes CD8+ T cell immunity by upregulating PD-L1 expression in lung cancer via PXN/AKT signaling phosphorylation and neutrophil chemotaxis 
The TOPK inhibitor HI-TOPK-032 enhances CAR T-cell therapy of hepatocellular carcinoma by upregulating memory T cells 
Enhanced T cell immune activity mediated by Drp1 promotes the efficacy of PD-1 inhibitors in treating lung cancer 
Mnox Nanoenzyme Armed CAR-NK Cells Enhance Solid Tumor Immunotherapy by Alleviating the Immunosuppressive Microenvironment 
Mitochondrial isocitrate dehydrogenase impedes CAR T?cell function by restraining antioxidant metabolism and histone acetylation 
PLA2G2A+ cancer-associated fibroblasts mediate pancreatic cancer immune escape via impeding antitumor immune response of CD8+ cytotoxic T cells 
评价
目前还没有评价